NIH ups its commitment to study harm reduction approaches

Abstract

The National Institutes of Health (NIH) last month announced the grant awardees for its new initiative representing its largest funding commitment yet to evaluating harm reduction approaches to reducing fatal overdoses. Among the concepts to be tested as part of NIH's harm reduction research network are mobile van‐delivered naloxone, contingency management strategies and “secondary distribution” of harm reduction supplies from one drug user to another.